Sign up
Healthed-White-on-Blue
Sarah Diepstraten

Sarah Diepstraten

Senior Research Officer, Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute
Sarah Diepstraten completed her PhD at La Trobe University in molecular genetics and developmental biology. She is now a post-doctoral scientist at the Walter and Eliza Hall Institute. Her research focuses on understanding how blood cancers become resistant to therapy and how this can be overcome. She develops genetic engineering approaches (CRISPR) to find genes involved in drug resistance. She has also taught in undergraduate science courses at La Trobe University and Melbourne University, and is passionate about science education.

More from this expert

shutterstock_1829931578

How does the drug abemaciclib treat breast cancer?

The anti-cancer drug abemaciclib (also known as Vernezio) has this month been added to the Australian Pharmaceutical Benefits Scheme (PBS) to treat certain types of breast cancer.

By Sarah Diepstraten, Dr John La Marca
Clinical Articles iconClinical Articles
shutterstock_1129964600

Are chemicals to blame for cancer in young people? Here’s what the evidence says

Here’s what the evidence says…

By Sarah Diepstraten, Dr John La Marca
Clinical Articles iconClinical Articles

Discover

Healthed

CPD platform

Last chance - $155 special ends midnight Sunday!

This is your last chance to secure discounted registration to both national seminars before prices increase on Monday! You're invited to attend Australia's most popular seminars for GPs and healthcare professionals.

Register for $155
WCH26 - Carousel Ad - MWCH26 date
WCH26 - Carousel Ad - SWCH26 date
WCH26 - Carousel Ad - BWCH26 date
WCH26 - Carousel Ad - PWCH26 date
WCH26 - Carousel Ad - AWCH26 date

Upcoming Healthed Webcast

POTS – What You Need to Know

Tuesday 17th February, 7pm - 9pm AEDT

Speaker

Prof Dennis Lau

Cardiac Electrophysiologist; The Royal Adelaide Hospital; Clinical Professor, The University of Adelaide

Hear the latest evidence-based management options for POTS - a common, yet poorly recognised and misunderstood autonomic dysfunction condition in our community. Join Prof Dennis Lau for an update on POTS, who is at risk, presenting symptoms and how it can be diagnosed in the primary care setting.

Register for webcast